Definitive Contract W911SR25CA008

The U.S. Army Research, Development and Engineering Command (RDECOM) awarded a $209.6K firm fixed-price definitive contract to The Tiny Cargo Company, a small business set-aside award, for proof-of-concept development to load monoclonal antibodies within GMP-grade milk and lyophilize the product for shelf stability testing. The work is to be performed in Roanoke, Virginia, with an ultimate completion date of May 22, 2026. The Tiny Cargo Company is a small business joint venture specializing in innovative medical technologies, particularly drug delivery platforms utilizing milk-derived extracellular vesicles (MEVs) for therapeutic applications.

This contract aligns with The Tiny Cargo Company's established research focus on developing novel oral therapeutics using MEV-based delivery systems, with prior support from the National Cancer Institute and National Science Foundation. The proof-of-concept effort to demonstrate monoclonal antibody loading and stability in milk-derived vehicles represents a critical developmental milestone that could support broader applications in drug delivery, including potential medical countermeasures for radiation-related therapeutic challenges. The fixed-price structure and defined completion timeline establish clear deliverables for this early-stage technology validation work.